Amedeo Smart

Free Medical Literature Service


 

Amedeo

Antiretroviral Therapy

  Free Subscription

Articles published in
N Engl J Med
    January 2024
  1. CAO B, Wang Y, Lu H, Huang C, et al
    Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19.
    N Engl J Med. 2024;390:230-241.
    >> Share

    June 2023
  2. CAO Z, Gao Y, Zhao R
    VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19. Reply.
    N Engl J Med. 2023;388:2396-2397.
    >> Share

  3. LI Y
    VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.
    N Engl J Med. 2023;388:2396.
    >> Share

  4. EDWARDS JL
    VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.
    N Engl J Med. 2023;388:2395-2396.
    >> Share

  5. BERGMANN F, Jorda A, Zeitlinger M
    VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.
    N Engl J Med. 2023;388:2395.
    >> Share

  6. LIN DY, Fleming TR
    VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.
    N Engl J Med. 2023;388:2395.
    >> Share

  7. OMBAJO LA, Penner J, Nkuranga J, Mecha J, et al
    Second-Line Switch to Dolutegravir for Treatment of HIV Infection.
    N Engl J Med. 2023;388:2349-2359.
    >> Share

    December 2022
  8. CAO Z, Gao W, Bao H, Feng H, et al
    VV116 versus Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19.
    N Engl J Med. 2022 Dec 28. doi: 10.1056/NEJMoa2208822.
    >> Share

    September 2022
  9. CHARNESS ME, Gupta K, Stack G, Strymish J, et al
    Rebound of SARS-CoV-2 Infection after Nirmatrelvir-Ritonavir Treatment.
    N Engl J Med. 2022 Sep 7. doi: 10.1056/NEJMc2206449.
    >> Share

  10. ANDERSON AS, Caubel P, Rusnak JM
    Nirmatrelvir-Ritonavir and Viral Load Rebound in Covid-19.
    N Engl J Med. 2022 Sep 7. doi: 10.1056/NEJMc2205944.
    >> Share

  11. PATEL K, Huo Y, Jao J, Powis KM, et al
    Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United States.
    N Engl J Med. 2022;387:799-809.
    >> Share

    February 2022
  12. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A New Antiviral against Covid-19.
    N Engl J Med. 2022;386:e25.
    >> Share

  13. HAMMOND J, Leister-Tebbe H, Gardner A, Abreu P, et al
    Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19.
    N Engl J Med. 2022 Feb 16. doi: 10.1056/NEJMoa2118542.
    >> Share

    December 2021
  14. TURKOVA A, White E, Mujuru HA, Kekitiinwa AR, et al
    Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children.
    N Engl J Med. 2021;385:2531-2543.
    >> Share

    August 2021
  15. LANDOVITZ RJ, Donnell D, Clement ME, Hanscom B, et al
    Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women.
    N Engl J Med. 2021;385:595-608.
    >> Share

    July 2021
  16. PATON NI, Musaazi J, Kityo C, Walimbwa S, et al
    Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV.
    N Engl J Med. 2021;385:330-341.
    >> Share

    December 2020
  17. PAN H, Peto R, Henao-Restrepo AM, Preziosi MP, et al
    Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
    N Engl J Med. 2020 Dec 2. doi: 10.1056/NEJMoa2023184.
    >> Share

    October 2020
  18. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Covid-19 and the President.
    N Engl J Med. 2020;383:e104.
    >> Share

  19. ARABI YM, Asiri AY, Assiri AM, Balkhy HH, et al
    Interferon Beta-1b and Lopinavir-Ritonavir for Middle East Respiratory Syndrome.
    N Engl J Med. 2020 Oct 7. doi: 10.1056/NEJMoa2015294.
    >> Share

    July 2020
  20. REGHUKUMAR A, Benson R
    Burning Pain in the Legs.
    N Engl J Med. 2020;383:e18.
    >> Share

    May 2020
  21. CAO B, Zhang D, Wang C
    A Trial of Lopinavir-Ritonavir in Covid-19. Reply.
    N Engl J Med. 2020;382.
    >> Share

  22. CARMONA-BAYONAS A, Jimenez-Fonseca P, Castanon E
    A Trial of Lopinavir-Ritonavir in Covid-19.
    N Engl J Med. 2020;382.
    >> Share

  23. CORRAO S, Natoli G, Cacopardo B
    A Trial of Lopinavir-Ritonavir in Covid-19.
    N Engl J Med. 2020;382.
    >> Share

  24. HAVLICHEK D JR
    A Trial of Lopinavir-Ritonavir in Covid-19.
    N Engl J Med. 2020;382.
    >> Share

  25. KUNZ KM
    A Trial of Lopinavir-Ritonavir in Covid-19.
    N Engl J Med. 2020;382.
    >> Share

  26. DALERBA P, Levin B, Thompson JL
    A Trial of Lopinavir-Ritonavir in Covid-19.
    N Engl J Med. 2020;382.
    >> Share

    March 2020
  27. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: New Research on Possible Treatments for Covid-19.
    N Engl J Med. 2020;382:e30.
    >> Share

  28. CAO B, Wang Y, Wen D, Liu W, et al
    A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.
    N Engl J Med. 2020 Mar 18. doi: 10.1056/NEJMoa2001282.
    >> Share

  29. BADEN LR, Rubin EJ
    Covid-19 - The Search for Effective Therapy.
    N Engl J Med. 2020 Mar 18. doi: 10.1056/NEJMe2005477.
    >> Share

  30. ORKIN C, Arasteh K, Hernandez-Mora MG, Pokrovsky V, et al
    Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection.
    N Engl J Med. 2020 Mar 4. doi: 10.1056/NEJMoa1909512.
    >> Share

    December 2019
  31. GOLDSTEIN RH, Walensky RP
    Where Were the Women? Gender Parity in Clinical Trials.
    N Engl J Med. 2019;381:2491-2493.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016